Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-01

FDA Approved: NICOTINE — Supplemental Application (H E B)

View source ↗

Summary

FDA approved a supplemental application for NICOTINE (nicotine and nicotine polacrilex) from H E B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NICOTINE POLACRILEX (nicotine polacrilex)
  • Nicotine (nicotine)

Snippet

SUPPL AP for NICOTINE (NICOTINE)